Copyright
©The Author(s) 2016.
World J Hepatol. Nov 28, 2016; 8(33): 1471-1477
Published online Nov 28, 2016. doi: 10.4254/wjh.v8.i33.1471
Published online Nov 28, 2016. doi: 10.4254/wjh.v8.i33.1471
Figure 1 Comparison of serum urokinase-type plasminogen activator receptor levels in biliary atresia patients and healthy controls.
uPAR: Urokinase-type plasminogen activator receptor; BA: Biliary atresia.
Figure 2 Comparison of serum urokinase-type plasminogen activator receptor levels in biliary atresia patients without jaundice and with jaundice.
uPAR: Urokinase-type plasminogen activator receptor.
Figure 3 Scatter diagram and regression analysis in biliary atresia patients.
uPAR levels are correlated with (A) serum aspartate aminotransferase (B) serum alanine aminotransferase (C) serum total bilirubin (D) serum alkaline phosphatase (E) serum albumin and (F) liver stiffness. uPAR: Urokinase-type plasminogen activator receptor.
- Citation: Udomsinprasert W, Honsawek S, Jirathanathornnukul N, Chongsrisawat V, Poovorawan Y. Elevation of serum urokinase plasminogen activator receptor and liver stiffness in postoperative biliary atresia. World J Hepatol 2016; 8(33): 1471-1477
- URL: https://www.wjgnet.com/1948-5182/full/v8/i33/1471.htm
- DOI: https://dx.doi.org/10.4254/wjh.v8.i33.1471